SCHEMBL6232522

SCHEMBL6232522

C=CC12CC[C@]3(C)CC(O)C[C@H]3[C@@H]1CCc1cc(O)ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 9/20 0.41
ESR1 P03372 8/20 0.41
ESR2 Q92731 7/20 0.41
PGR P06401 2/20 0.38
HSD17B10 Q99714 3/20 0.37
LMNA P02545 3/20 0.37
TSHR P16473 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
HIF1A Q16665 2/20 0.37
CYP1A2 P05177 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SLC22A1 O15245 1/20 0.37
AKR1B10 O60218 1/20 0.37
SLC22A3 O75751 1/20 0.37
ABCB11 O95342 1/20 0.37
ESRRB O95718 1/20 0.37
ALDH1A1 P00352 1/20 0.37
SHBG P04278 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1829950 1.00 NR3C1 (0.41) NR3C1ESR1ESR2PGRHSD17B10
SCHEMBL6232518 1.00 NR3C1 (0.41) NR3C1ESR1ESR2PGRHSD17B10
SCHEMBL6233085 0.89 NR3C1 (0.41) NR3C1ESR1ESR2PGRHSD17B10
SCHEMBL4587414 0.89 NR3C1 (0.41) NR3C1ESR1ESR2PGRHSD17B10
SCHEMBL6233082 0.89 NR3C1 (0.41) NR3C1ESR1ESR2PGRHSD17B10
SCHEMBL4587411 0.89 NR3C1 (0.41) NR3C1ESR1ESR2PGRHSD17B10
SCHEMBL4588729 0.88 NR3C1 (0.52) NR3C1ESR1ESR2PGRHSD17B10
SCHEMBL2215608 0.87 NR3C1 (0.40) NR3C1ESR1ESR2PGRHSD17B10
SCHEMBL4589641 0.86 LMNA (0.39) ESR1HSD17B10LMNATSHRCYP2C9
SCHEMBL4587939 0.85 NR3C1 (0.41) NR3C1ESR1ESR2PGRAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517914-A2 9-ALPHA-SUBSTITUTED ESTRATRIENES AS SELECTIVELY ACTIVE ESTROGEN Schering Aktiengesellschaft (DE) 2005-03-30 EP disclosed
WO-2003104253-A2 9-ALPHA-SUBSTITUTED ESTRATRIENES AS SELECTIVELY ACTIVE ESTROGEN SCHERING AKTIENGESELLSCHAFT (DE) 2003-12-18 WO disclosed